drugset / Trial / NCT00198315

Medpulser Electroporation With Bleomycin Study to Treat Anterior Head and Neck Squamous Cell Carcinoma

NCT00198315

Phase 3 Terminated 130 enrolled Inovio Pharmaceuticals
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of the study is to evaluate Medpulser electroporation (EPT) with bleomycin with regard to local tumor recurrence, disease-free survival, and overall survival rates versus surgery in recurrent or secondary primary squamous cell carcinoma (SCC) of the anterior oral cavity, soft palate, or tonsil.

Timeline

Start
2004-06
Primary completion
2007-06
Completion
2007-06-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Bleomycin Unknown Other

Indications